An Israeli newspaper reported that the case of double infection was found in a woman who entered the Rabin Medical Center this week to give birth.
JERUSALEM: Amid the ongoing worldwide pandemic of coronavirus, Israel has now reported its first case of "Florona" disease, a double infection of COVID-19 and Influenza, said reports on Thursday. . Meanwhile, Israel approved a fourth dose of the vaccine for people hit by COVID-19 - making it one of the first countries to do so. Nachman Aish, Director General of the Ministry of Health, announced the decision while addressing a press conference on Thursday, informing that people with weakened immune systems would be given the first dose. The Associated Press (AP) quoted him as saying, "We will continue to track the data on a daily basis and we will see if we need to expand this recommendation to a greater population." Also Read - Paris Or Hong Kong, It Is Now The Most Expensive City In The World To Live In full list here
Israel began testing a fourth dose at the center earlier this week, giving it to 150 medical workers who had already taken a booster shot in August. About a year ago, Israel was one of the first countries to launch Pfizer's vaccine and began giving booster doses last summer.
However, the country has still seen a large number of cases driven by the delta version of the virus and officials have warned of another surge in cases driven by the Omicron version.
COVID cases in Israel
Israel currently has about 22,000 active patients, of whom more than 90 are in extremely critical condition. The country has reported at least 8,243 deaths from COVID-19 since the pandemic began. It should be noted here that last week, Chile announced that it would begin offering a fourth dose in February.
Israel Pfizers is one of the first countries to receive Paxlovid, a drug that can be used at home to prevent the most severe symptoms of the virus. All previously approved drugs require the use of an IV or injection. According to Israeli media, the first shipment includes 20,000 doses, and there are more to come as Pfizer ramps up manufacturing.